How Oligonucleotides Work Their Magic
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
False
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
By Stephanie Vine
August 14, 2025
Targeting disease at the genetic level isn’t science fiction – it’s oligonucleotides. Hilary Brooks reveals how smarter discovery strategies are reshaping what’s possible in drug development.
10 min read
August 13, 2025
Nominations are now open for The Medicine Maker 2025 Innovation Awards celebrating drug development and manufacturing technologies.
2 min read
By Stephanie Vine, Rob Coker
July 24, 2025
Experts give their views on why the potential future offered by personalized medicine is so exciting.
By Stephanie Vine
July 14, 2025
What comes next for cancer drug development? AbbVie’s Eleni Lagkadinou discusses precision, AI, and her hope for turning cancer into a more chronic, manageable condition.
11 min read
By Rob Coker
May 14, 2025
Let us not forget the important role of academic spinouts in innovating across the modalities.
3 min read
By Stephanie Vine
May 1, 2025
Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.
5 min read
April 8, 2025
We asked experts about their views of the future of pharma. Process digitization, data, and sustainability are key themes.
4 min read
By Rob Ellison
March 31, 2025
An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.
7 min read
March 27, 2025
Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D
2 min read
False
False
False